Back

Colchicine for the secondary prevention of cardiovascular diseases: a cumulative-dose meta-analysis of randomized controlled trials including 31,397 subjects worldwide

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes (3) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Assistant Professor Yap-Hang Will Chan

The University of Hong Kong, Hong Kong (Hong Kong)

6 More presentations in this session

Presentation thumbnail
Comparative effectiveness of prasugrel and ticagrelor among patients undergoing contemporary PCI: insights from the BMC2 registry
Doctor E. Dayoub (Ann Arbor, US)
Abstract Slides Video
Presentation thumbnail
Effect of early initiation of evolocumab on lipid profiles changes in patients with ACS Undergoing PCI (C-STAR)
Associate Professor Y. Kim (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Early TNF-alpha levels suppression by upstream evolocumab use in patients with acute myocardial infarction undergoing percutaneous coronary intervention
Doctor A. Marengo (Novara, IT)
Abstract Slides Video
Presentation thumbnail
Direct oral anticoagulants vs. vitamin K antagonists for left ventricular thrombus: a paradigm shift in antithrombotic strategy?
Doctor F. Veneziano (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
A very short duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials
Doctor J. Sakaleros (Bloomington, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Smaller trials, trial updates, and other studies on inflammation and immunity in cardiovascular disease
thumbnail
Congress Presentation
Colchicine in acute coronary syndrome: an updated meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Top prevention papers in the EHJ

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources